Your browser doesn't support javascript.
loading
Amelioration of Fibrotic Remodeling of Human 3-Dimensional Full-Thickness Skin by Transglutamase 2 Inhibition.
Zhou, Xiang; Trinh-Minh, Thuong; Matei, Alexandru-Emil; Györfi, Andrea-Hermina; Hong, Xuezhi; Bergmann, Christina; Schett, Georg; Atkinson, John; Bowcutt, Rowann; Patel, Jessal; Johnson, Timothy S; Distler, Jörg H W.
Afiliação
  • Zhou X; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
  • Trinh-Minh T; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
  • Matei AE; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
  • Györfi AH; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
  • Hong X; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
  • Bergmann C; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, and Deutsches Zentrum Immuntherapie (DZI), FAU Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
  • Schett G; Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, and Deutsches Zentrum Immuntherapie (DZI), FAU Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
  • Atkinson J; UCB BioPharma, Slough, UK.
  • Bowcutt R; UCB BioPharma, Slough, UK.
  • Patel J; UCB BioPharma, Slough, UK.
  • Johnson TS; UCB BioPharma, Slough, UK.
  • Distler JHW; Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, and Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
Arthritis Rheumatol ; 75(9): 1619-1627, 2023 09.
Article em En | MEDLINE | ID: mdl-37057394
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha